Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03929432 · ClinicalTrials.gov registry record · NA
Treatment Outcomes With tDCS in Post-Stroke Aphasia
A NA study of Aphasia, sponsored by University of Arkansas.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03929432: Recruiting NA study of Aphasia, sponsored by University of Arkansas.
NCT03929432 is a NA study of Aphasia that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 50 participants, below the 82-participant average among 42 other Aphasia trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03929432, a NA study of Aphasia, is actively recruiting participants, sponsored by University of Arkansas.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose this study is to test the utility of pairing external neuromodulation with behavioral language treatment to boost therapy outcomes and to investigate the mechanisms associated with recovery. Because all PWA have word retrieval deficits, this project will test if greater language gains can be achieved by supplementing anomia intervention with excitatory brain stimulation to the left hemisphere and will evaluate associated functional brain changes to aid the optimization of neural reorganization to facilitate language processing.
Primary Outcome
Naming gains for untreated items.
Conditions Studied
Interventions
- DEVICE Active Transcranial Direct Current Stimulation with SLT
- DEVICE Sham Transcranial Direct Current Stimulation with SLT
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-09-03 |
| Est. Completion | 2029-12 |
| Phase | NA |
What NCT03929432 shows while recruiting
NCT03929432 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 82-participant average among 42 other Aphasia trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Aphasia appearing as the primary indexed condition, and to 2 interventions - of which Active Transcranial Direct Current Stimulation with SLT is the first listed.
NCT03929432 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT03929432 about?
NCT03929432 is a clinical study titled "Treatment Outcomes With tDCS in Post-Stroke Aphasia". The purpose this study is to test the utility of pairing external neuromodulation with behavioral language treatment to boost therapy outcomes and to investigate the mechanisms associated with recovery. Because all PWA have word retrieval deficits, this project will test if greater language gains ca...
What is the current status of trial NCT03929432?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2019-09-03. Estimated completion is 2029-12.
What conditions does trial NCT03929432 study?
This clinical trial studies the following conditions: Aphasia.
What interventions are being tested in trial NCT03929432?
The interventions under investigation include: Active Transcranial Direct Current Stimulation with SLT (DEVICE), Sham Transcranial Direct Current Stimulation with SLT (DEVICE).
Who is sponsoring clinical trial NCT03929432?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03929432 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03929432's enrollment target sits among peer trials
50 24th of 42 higher than 15 of 42 other Aphasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aphasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Transcranial Alternating Current Stimulation (tACS) in Aphasia
RECRUITING · NA
-
tACS to Enhance Language Abilities
RECRUITING · NA
-
Telerehabilitation for Aphasia (TERRA)
RECRUITING · NA
-
Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits
RECRUITING · NA
-
Sentence Production Training in Aphasia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI